2020 Financial Year Results

2020 Financial Year Results

 

During a year of unprecedented uncertainty due to the COVID-19 pandemic, the IASO Group continued implementing its growth plan, while improving its financials and results.

At the same time, with heightened alertness and a deep sense of responsibility, the IASO Group remained at the frontline of healthcare developments, fully meeting the medical and hospitalization needs of patients, in line with the guidelines of the Greek Ministry of Health and the instructions of the Infection Control Committee.

The 2020 results for IASO, on a company and a consolidated level, as arising from the published financial statements, are listed below:

A) COMPANY

TURNOVEREarnings before interest, taxes, depreciation and amortization (EBITDA) amounted to €17.46m, as opposed to €17.02m in 2019, up by 2.6%. The corresponding margin amounted to 23.1% against sales.  

EARNINGS BEFORE TAX: The company recorded earnings before tax of €9.69m, as opposed to €4.54m in 2019, increasing by 113.4%.

EARNINGS AFTER TAX: Earnings after tax stood at €5.39m as opposed to net earnings of €3.84m in 2019, increasing by 40.4%.  

B) GROUP

TURNOVER: On a consolidated level, turnover amounted to €97.01m in 2020, as opposed to €95.71m during the previous financial year, recording a 1.4% rise.

EARNINGS BEFORE TAX: The Group ended the 2020 financial year with €3.66m in earnings before tax, as opposed to €8.89m in losses in 2019. The profitability in the 2020 financial year was affected by final consolidation accounting entries linked to the sale and deconsolidation of FILOKTITIS.

EARNINGS AFTER TAX: : In terms of results after tax, losses of €0.9m were recorded, as opposed to losses of €10.82m in 2019.

 

 

 

The strong financial position of IASO, coupled with it improving results, ensure the smooth continuation of activities. However, a potential continuation of the lockdown could have a negative effect on the purchasing power of consumers and, by extension, on the demand for private healthcare services.

The financial statements will be posted on the websites of the Athens Exchange (www.helex.gr) and the company(www.iaso.gr/en)

 

From the Press Office

For more news-related information: Thanasis Papadis, Head of the IASO Group Press Office, Tel. +30 2106383972, +30 6974441150, +30 6944346076, Ε-mail: papadis@iaso.grand Nancy Christopoulou, Commercial Division of the IASO Group, Tel.: +30 2106383917, E-mail: [email protected]

    View also:

    IASO General Clinic: Make prevention a habit!
    GENERAL

    IASO General Clinic: Make prevention a habit!

    Movember: Check-up packages for men at exclusive pricesIASO General Clinic is once again actively participating in the global Movember movement, aiming to inform an...

    IASO: Neonatal BabyGen – Neonatal Genomic Screening
    MATERNITY - GYNECOLOGY

    IASO: Neonatal BabyGen – Neonatal Genomic Screening

    IASO, the largest Maternity & Gynecology Clinic in Europe, in collaboratio...

    IASO General Clinic: MOZART® Specimen Tomosynthesis System - Augmented Intelligence for more accurate and safe breast surgeries
    GENERAL

    IASO General Clinic: MOZART® Specimen Tomosynthesis System - Augmented Intelligence for more accurate and safe breast surgeries

    Extensive imaging & intraoperative insights It constitutes the most advanced technology worldwide in intraoperative breast tissue imag...